Tiny study aims to unlock how blood filtering helps CIDP
NCT ID NCT04742374
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looked at two types of plasmapheresis (blood filtering) in 8 people with CIDP, a rare nerve disorder causing weakness. The goal was to see how each method affects immune cells in the blood. It is a very early, small study focused on understanding how these treatments work, not on finding a cure.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- plasmapheresis (blood filtering)
- What this could lead to
- If successful, this could help doctors understand why plasmapheresis works for CIDP and choose the best technique.
- What could go wrong
- This is a very small, early-phase study with only 8 people. It is designed to gather information, not to prove a treatment works. Results may not apply to all CIDP patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POLYRADICULONEUROPATHY, CHRONIC INFLAMMATORY DEMYELINATING are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Olivier MORANNE
Nîmes, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.